Dyne Therapeutics' early trial results for DM1 and DMD treatments show dose-dependent improvements, but data is preliminary. Despite promising DYNE-101 and DYNE-251 outcomes, limited participant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback